类有机物
癌症研究
生物
体内
克拉斯
移植
结直肠癌
癌症
腺癌
胰腺
胰腺癌
永生化细胞系
间充质干细胞
细胞培养
细胞生物学
医学
内科学
生物化学
遗传学
作者
Xingnan Li,Lincoln Nadauld,Akifumi Ootani,David C. Corney,Reetesh K. Pai,Olivier Gevaert,Michael A. Cantrell,Philip D. Rack,James T. Neal,Carol W-M Chan,Trevor M. Yeung,Xue Gong,Jing Yuan,Julie Wilhelmy,Sylvie Robine,Laura D. Attardi,Sylvia K. Plevritis,Kenneth E. Hung,Chang Zheng Chen,Hanlee P. Ji,Calvin J. Kuo
出处
期刊:Nature Medicine
[Springer Nature]
日期:2014-05-25
卷期号:20 (7): 769-777
被引量:366
摘要
Modeling and documenting malignant progression in vitro without the need for in vivo transplantation represents a clear step forward for cancer investigation. Using an air-liquid interface methodology, Xingnan Li and colleagues show they can robustly model a range of gastrointestinal malignancies from pancreas, stomach and colon in primary epithelial/mesenchymal organoid culture. This setup is able to generate detailed histologic endpoints for oncogenic transformation in vitro and demonstrate in vivo tumorigenicity when the organoids are transplanted. The application of primary organoid cultures containing epithelial and mesenchymal elements to cancer modeling holds promise for combining the accurate multilineage differentiation and physiology of in vivo systems with the facile in vitro manipulation of transformed cell lines. Here we used a single air-liquid interface culture method without modification to engineer oncogenic mutations into primary epithelial and mesenchymal organoids from mouse colon, stomach and pancreas. Pancreatic and gastric organoids exhibited dysplasia as a result of expression of Kras carrying the G12D mutation (KrasG12D), p53 loss or both and readily generated adenocarcinoma after in vivo transplantation. In contrast, primary colon organoids required combinatorial Apc, p53, KrasG12D and Smad4 mutations for progressive transformation to invasive adenocarcinoma-like histology in vitro and tumorigenicity in vivo, recapitulating multi-hit models of colorectal cancer (CRC), as compared to the more promiscuous transformation of small intestinal organoids. Colon organoid culture functionally validated the microRNA miR-483 as a dominant driver oncogene at the IGF2 (insulin-like growth factor-2) 11p15.5 CRC amplicon, inducing dysplasia in vitro and tumorigenicity in vivo. These studies demonstrate the general utility of a highly tractable primary organoid system for cancer modeling and driver oncogene validation in diverse gastrointestinal tissues.
科研通智能强力驱动
Strongly Powered by AbleSci AI